Skip to main content
. 2006 May 4;574(Pt 2):573–581. doi: 10.1113/jphysiol.2006.108993

Table 2.

Thresholds for cutaneous vasodilatation: absolute Tor and ΔTor

Young Older


Tor (°C) ΔTor (°C) Tor (°C) ΔTor (°C)
Control 36.74 ± 0.10 0.41 ± 0.07 36.76 ± 0.09 0.57 ± 0.06*
NOS inhibited 36.89 ± 0.08 0.56 ± 0.04 36.94 ± 0.06 0.75 ± 0.05*
Arginase inhibited 36.73 ± 0.11 0.40 ± 0.06 36.69 ± 0.07 0.50 ± 0.05
l-Arg supplemented 36.95 ± 0.13 0.52 ± 0.05 36.70 ± 0.09 0.52 ± 0.05
Arginase inhibited +
l-Arg supplemented 36.75 ± 0.10 0.42 ± 0.06 36.73 ± 0.09 0.54 ± 0.07*

Values are means ± s.e.m.; Tor, oral temperature; ΔTor, change in oral temperature from baseline; NOS, nitric oxide synthase; l-Arg, l-arginine.

*

Significant difference versus young subject group (P < 0.05).

Significant difference versus control site within the older subject group (P < 0.05).

Significant difference versus control site within the young subject group (P < 0.05).

HHS Vulnerability Disclosure